Matches in SemOpenAlex for { <https://semopenalex.org/work/W3092488426> ?p ?o ?g. }
- W3092488426 endingPage "3058" @default.
- W3092488426 startingPage "3044" @default.
- W3092488426 abstract "The aim of this study was to investigate the role of scoparone (SCO) in hepatic fibrosis. For this, we conducted in vivo and in vitro experiments. In vivo rats that were divided into six groups, control, carbon tetrachloride, and colchicine, as well as SCO groups, SCO50, SCO100, and SCO200 treated with 50, 100, and 200 mg/kg SCO doses, respectively. Furthermore, SCO was shown to inhibit Toll-like receptor-4 (TLR-4)/nuclear factor kappa-B (NF-κB; TLR-4/NF-κB) signals by inhibiting TLR-4, which in turn downregulates the expression of MyD88, promotes NF-κB inhibitor-α, NF-κB inhibitor-β, and NF-κB inhibitor-ε activation, while inhibiting NF-κB inhibitor-ζ. Subsequently, the decrease of phosphorylation of nuclear factor-κB levels leads to the downregulation of the downstream inflammatory factors' tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), and IL-1 beta, thus weakening hepatic fibrosis. Notably, the SCO200 treated group presented the most significant improvement. Hence, we conclude that SCO alleviates hepatic fibrosis by inhibiting TLR-4/NF-κB signals." @default.
- W3092488426 created "2020-10-15" @default.
- W3092488426 creator A5019960596 @default.
- W3092488426 creator A5027117240 @default.
- W3092488426 creator A5030528553 @default.
- W3092488426 creator A5031503097 @default.
- W3092488426 creator A5039583444 @default.
- W3092488426 creator A5042973871 @default.
- W3092488426 creator A5052787170 @default.
- W3092488426 creator A5058888901 @default.
- W3092488426 creator A5062165404 @default.
- W3092488426 creator A5069779034 @default.
- W3092488426 creator A5070995681 @default.
- W3092488426 creator A5073437466 @default.
- W3092488426 creator A5073530299 @default.
- W3092488426 creator A5088518232 @default.
- W3092488426 date "2020-10-08" @default.
- W3092488426 modified "2023-10-17" @default.
- W3092488426 title "Scoparone alleviates hepatic fibrosis by inhibiting the TLR‐4/NF‐κB pathway" @default.
- W3092488426 cites W1983846332 @default.
- W3092488426 cites W1987976516 @default.
- W3092488426 cites W2042433863 @default.
- W3092488426 cites W2050461151 @default.
- W3092488426 cites W2068380311 @default.
- W3092488426 cites W2091405607 @default.
- W3092488426 cites W2094133741 @default.
- W3092488426 cites W2095853585 @default.
- W3092488426 cites W2109194302 @default.
- W3092488426 cites W2160321267 @default.
- W3092488426 cites W2198881207 @default.
- W3092488426 cites W2201301173 @default.
- W3092488426 cites W2271008887 @default.
- W3092488426 cites W2288348768 @default.
- W3092488426 cites W2288393153 @default.
- W3092488426 cites W2298031561 @default.
- W3092488426 cites W2323780569 @default.
- W3092488426 cites W2324061288 @default.
- W3092488426 cites W2344120572 @default.
- W3092488426 cites W2592268566 @default.
- W3092488426 cites W2603291804 @default.
- W3092488426 cites W2606276465 @default.
- W3092488426 cites W2614986146 @default.
- W3092488426 cites W2625727020 @default.
- W3092488426 cites W2626980266 @default.
- W3092488426 cites W2731897549 @default.
- W3092488426 cites W2741237430 @default.
- W3092488426 cites W2768160230 @default.
- W3092488426 cites W2768618587 @default.
- W3092488426 cites W2769093727 @default.
- W3092488426 cites W2769563209 @default.
- W3092488426 cites W2770797452 @default.
- W3092488426 cites W2790373475 @default.
- W3092488426 cites W2792779377 @default.
- W3092488426 cites W2793242800 @default.
- W3092488426 cites W2804020656 @default.
- W3092488426 cites W2883843668 @default.
- W3092488426 cites W2887689841 @default.
- W3092488426 cites W2894656762 @default.
- W3092488426 cites W2900343570 @default.
- W3092488426 cites W2927710716 @default.
- W3092488426 cites W2952302425 @default.
- W3092488426 cites W2968678670 @default.
- W3092488426 cites W2973223101 @default.
- W3092488426 cites W2981030134 @default.
- W3092488426 cites W2981571489 @default.
- W3092488426 cites W2982910767 @default.
- W3092488426 cites W2984059297 @default.
- W3092488426 cites W2985041367 @default.
- W3092488426 cites W2985713079 @default.
- W3092488426 cites W2986640601 @default.
- W3092488426 cites W2986691533 @default.
- W3092488426 cites W2994263573 @default.
- W3092488426 doi "https://doi.org/10.1002/jcp.30083" @default.
- W3092488426 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33090488" @default.
- W3092488426 hasPublicationYear "2020" @default.
- W3092488426 type Work @default.
- W3092488426 sameAs 3092488426 @default.
- W3092488426 citedByCount "6" @default.
- W3092488426 countsByYear W30924884262022 @default.
- W3092488426 countsByYear W30924884262023 @default.
- W3092488426 crossrefType "journal-article" @default.
- W3092488426 hasAuthorship W3092488426A5019960596 @default.
- W3092488426 hasAuthorship W3092488426A5027117240 @default.
- W3092488426 hasAuthorship W3092488426A5030528553 @default.
- W3092488426 hasAuthorship W3092488426A5031503097 @default.
- W3092488426 hasAuthorship W3092488426A5039583444 @default.
- W3092488426 hasAuthorship W3092488426A5042973871 @default.
- W3092488426 hasAuthorship W3092488426A5052787170 @default.
- W3092488426 hasAuthorship W3092488426A5058888901 @default.
- W3092488426 hasAuthorship W3092488426A5062165404 @default.
- W3092488426 hasAuthorship W3092488426A5069779034 @default.
- W3092488426 hasAuthorship W3092488426A5070995681 @default.
- W3092488426 hasAuthorship W3092488426A5073437466 @default.
- W3092488426 hasAuthorship W3092488426A5073530299 @default.
- W3092488426 hasAuthorship W3092488426A5088518232 @default.
- W3092488426 hasConcept C104317684 @default.
- W3092488426 hasConcept C123298856 @default.
- W3092488426 hasConcept C126322002 @default.